Bio
Claus Jacob is a German scientist functioning as the Head of Bioorganic Chemistry, at the School of Pharmacy, Saarland University. He received his B.Sc.(Hons) 1st class in Chemistry in 1993 from the University of Leicester, England, and his DPhil (Oxon) from the University of Oxford in 1997 under the supervision of Allen Hill. His interests in philosophy, history and psychology led to a Magister Artium (MA) degree from the University of Hagen in 1998. He has been a postdoctoral researcher at Harvard Medical School with Bert Vallee and a (senior) lecturer at the University of Exeter before returning to the Saarland in 2005. Claus is an expert in a variety of topics ranging from organic synthesis, bioorganic chemistry, catalytic sensor/effector agents, intracellular diagnostics, nanotechnology, natural products, reactive sulfur and selenium species, and redox regulation via the cellular thiolstat to philosophical, social aspects and environmental aspects of science. He has contributed more than 200 publications in the previously mentioned fields (H-index 61). He is Section Editor-in-Chief in Antioxidants, Section Board Member in Molecules, Editor-in-Chief of Sci and two other journals in the fields of sustainable chemistry and nutrition and is politically active on an ecological democratic platform.

Talk
Modulation of Reactive Nitric Oxide in Drug Discovery: Photoresponsive Systems for Precision Control

Bio
Dr Gregory Giles is the Director of Biomedical Sciences at the University of Otago (New Zealand). His research focusses on the therapeutic applications of drugs that modulate levels of reactive oxygen, nitrogen and sulfur species. He has published over 70 scientific articles (~5,000 citations, h-index 31, Google Scholar) and served as an Editor for Current Nutraceuticals and Antioxidants.

Talk
Selenotriazines: A Path to Neuroprotection and Treatment of Alzheimer's Disease

Bio
Prof. Cecilia Battistelli is Associate Professor at the Department of Molecular Medicine, Sapienza University of Rome, Italy. Her research interests are focused on molecular mechanisms controlling cell plasticity i.e. cell differentiation, epithelial-to-mesenchymal transition and tumour onset and dissemination, and mediated by extracellular vesicles, non-codingRNAs, epigenetic/epitranscriptomic modifications and RNA-binding proteins. Moreover, she is involved in the validation of different drugs able to modulate gene expression in epithelial to mesenchymal transition, in tumorigenesis and in the onset and development of neurodegenerative diseases (e.g. Alzheimer’s disease). She has co-authored 58 original articles in peer reviewed journals (H-index 25 (Scopus Author ID 55371458900), she is member of Editorial Boards for 4 International scientific Journals, and she served as Guested Editor for 4 special Issues. She is Member of International Societies, and she recently obtained fundings for her Research activity on the role of epigenetics and noncoding genome on tumor development. She has ongoing collaboration with Scientists from different countries and Institutions (University College of London; Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid; Centro De Biología Molecular Severo Ochoa, Madrid; Jagiellonian University, Kraków; Universität des Saarlandes, Saarbrücken, Germany; Bambino Gesù Childrens’ Hospital, Rome). She was recipient of 7 awards from International and National Scientific Societies for her Research.

Bio
Ahmad Yaman Abdin is a postdoctoral researcher at the Institute for Bioorganic Chemistry, School of Pharmacy, Saarland University, Germany. His work centers on the philosophical, social, and psychological aspects of pharmacy, with a particular focus on drug development, regulation, and application. Yaman has been actively involved in international research, including time at UCCS–Unite de Catalyse et Chimie du Solide, University of Artois, Lille, France. He also volunteered with the National Society for Multiple Sclerosis in the USA. He has presented at and organized several international conferences, and has an H-index of 11. Yaman leads the 'Pharmasophy' group at the Institute for Bioorganic Chemistry.